Talon Therapeutics (TLON)
Create an AlertTLON Key Stats
| Income Statement | |
| Revenue TTM | 0.00 |
| Revenue Quarterly YoY Growth | |
| EPS Diluted TTM | -4.152 |
| EPS Diluted Quarterly YoY Growth | |
| Net Income TTM | -43.70M |
| Profitability | |
| Gross Profit Margin Quarterly | |
| Profit Margin Quarterly | |
| Dividend | |
| Dividend Yield | 0.00% |
| Payout Ratio TTM Pro | Go Pro |
| Current Valuation | |
| Market Cap | 8.80M |
| Enterprise Value | 30.66M |
| PE Ratio TTM | |
| PE 10 Pro | Go Pro |
| PEG Ratio | |
| Price / Book Value | |
| Other | |
| Beta Pro | Go Pro |
| Debt to Equity Ratio | |
| Free Cash Flow | |
| Return on Equity | |
TLON News
- Talon Therapeutics, Inc. Reports First Quarter 2013 Financial Results GlobeNewswire May 15
- TALON THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report May 15
- TALON THERAPEUTICS, INC. Financials Apr 6
- Biotechs With Staggering Potential: Grant Zeng Apr 5
- Talon Therapeutics' CEO Discusses Q4 2012 Results - Earnings Call Transcript Seeking Alpha Apr 1
- Talon Therapeutics, Inc. Reports Fourth Quarter and Year End 2012 Financial Resu... Apr 1
- TALON THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial... Apr 1
- Talon Therapeutics to Host a Conference Call to Report 2012 Financial Results an... Mar 19
- TALON THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Of... Jan 25
- TALON THERAPEUTICS, INC. Files SEC form 8-K, Unregistered Sale of Equity Securit... Jan 11
TLON Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Talon Therapeutics is down 51.22% over the last year vs S&P 500 Total Return up 24.84%, Alnylam Pharmaceuticals up 156.7%, and Tekmira Pharmaceuticals Corporation up 139.9%.
TLON Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these TLON related companies
Pro Ratings for TLON
Pro Strategies Featuring TLON
Did Talon Therapeutics make it into our Pro Portfolio Strategies?
Start your YCharts Pro membership now to find out.
TLON Profile
Sector: Healthcare
Industry: Biotechnology
Other TLON Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TLON | 0.40 | +0.00 | +0.00% | 8.80M |
